Resistance to Androgen Deprivation Leads to Altered Metabolism in Human and Murine Prostate Cancer Cell and Tumor Models
Currently, no clinical methods reliably predict the development of castration-resistant prostate cancer (CRPC) that occurs almost universally in men undergoing androgen deprivation therapy. Hyperpolarized (HP) <sup>13</sup>C magnetic resonance imaging (MRI) could potentially detect the i...
Main Authors: | Jinny Sun, Robert A Bok, Justin DeLos Santos, Deepti Upadhyay, Romelyn DeLos Santos, Shubhangi Agarwal, Mark Van Criekinge, Daniel B Vigneron, Rahul Aggarwal, Donna M Peehl, John Kurhanewicz, Renuka Sriram |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/11/3/139 |
Similar Items
-
How do we define “castration” in men on androgen deprivation therapy?
by: Sarin Itty, et al.
Published: (2020-01-01) -
Clamp ablation of the testes compared to bilateral orchiectomy as androgen deprivation therapy for advanced prostate cancer
by: AD Zarrabi, et al.
Published: (2011-06-01) -
Functional and structural changes in internal pudendal arteries underlie erectile dysfunction induced by androgen deprivation
by: Rhéure Alves-Lopes, et al.
Published: (2017-01-01) -
Origin of Androgen-Insensitive Poorly Differentiated Tumors in the Transgenic Adenocarcinoma of Mouse Prostate Model
by: Wendy J. Huss, et al.
Published: (2007-11-01) -
The castration level of testosterone and hormonal resistance of prostate cancer in androgen deprivation therapy
by: I. G. Rusakov, et al.
Published: (2020-12-01)